shuttlepharma.com (SHPH) - יתרות המזומנים של החברה

Shuttle Pharmaceuticals (SHPH) possesses significant pricing power in radio-oncology due to its life-saving drugs. The change in cash asset volume visualizes current liquidity, where the value of 0.00 reflects this status. A team of motivated radiobiologists is focused on prostate and brain cancer therapies. Shuttle Pharmaceuticals (SHPH) successfully offsets its internal staffing shortage through targeted hiring and external outsourcing.
Shuttle Pharmaceuticals Holdings - פילוחים אנליטיים ומדדי מפתח (SHPH)

Shuttle Pharmaceuticals (SHPH) competes in the high-risk oncology drug development sector. This metric aggregates all cash and cash equivalents, quantifying the business's ability to fund R&D without external borrowing. The indicator measures the balance between volatility protection and capital efficiency. For Shuttle Pharmaceuticals (SHPH), this is a critical indicator of the burn rate of reserves used to create sensitizers. By analyzing the structure of cash balances, an investor determines the management's autonomy horizon.